Classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder in a kidney transplant recipient: a diagnostic pitfall
We report a case of classical Hodgkin lymphoma type post-transplant lymphoproliferative disorder (HL-PTLD) after kidney transplantation to highlight the difficulty of distinguishing this disorder from Hodgkin lymphoma-like PTLD (HL-like PTLD). Through this case report and literature review, we seek to clarify definitive pathologic features to differentiate these two conditions. A 38-year-old male kidney transplant recipient who had been receiving immunosuppressants was admitted to our hospital with unidentified high fever. Computed tomography images and blood tests indicated a lymphoproliferative disorder. Abdominal lymph node biopsy was performed, and microscopic examination revealed the presence of many large atypical cells in a background of dense T cell accumulation. The large, atypical cells were positive for Epstein–Barr Virus (EBV)-encoded small RNAs (EBER) in situ hybridization, EBV-LMP1, CD30 and PAX5, but negative for CD15, CD20 and CD45. Except for CD15-negativity, this immunohistochemical pattern was consistent with that of classical Hodgkin lymphoma. By close examination of the above immunoreactivities and the patient’s subsequent chemosensitive clinical course, we finally made a diagnosis of HL-PTLD.
KeywordsClassical Hodgkin lymphoma Post-transplant lymphoproliferative disorder Immunohistochemistry
The authors thank Mr. Ben Phillis, Wakayama Medical University, for proofreading and editing the manuscript.
Compliance with ethical standards
Conflict of interest
All authors have nothing to disclose.
- 1.Swerdlow SH, Webber SA, Chadburn A, Ferry JA. Post-transplant lymphoproliferative disorders. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 453–62.Google Scholar
- 8.Lister J, Simpson JK, deMagalhaes-Silverman MM, Rybka WB, Donnenberg AD, Myers DJ, et al. Allogeneic peripheral blood stem cell transplant for myelodysplasia after chemotherapy for post-transplant lymphoma in a cardiac transplant recipient at 10 years. Bone Marrow Transpl. 1997;19:943–5.CrossRefGoogle Scholar
- 9.Chetty R, Biddolph S, Gatter K. An immunohistochemical analysis of Reed-Sternberg-like cells in posttransplantation lymphoproliferative disorders: the possible pathogenetic relationship to Reed-Sternberg cells in Hodgkin’s disease and Reed-Sternberg-like cells in non-Hodgkin’s lymphomas and reactive conditions. Hum Pathol. 1997;28:493–8.CrossRefPubMedGoogle Scholar
- 17.Yagi T, Ishikawa J, Aono N, Yamashita Y, Kusakabe S, Yoshinami T, et al. Epstein–Barr virus-associated post-transplant lymphoproliferative disorders after allogeneic peripheral blood stem cell transplantation for Hodgkin-like adult T-cell leukemia/lymphoma. Int J Hematol. 2012;95:214–6.CrossRefPubMedGoogle Scholar
- 18.Basso S, Zecca M, Calafiore L, Rubert L, Fiocchi R, Paulli M, et al. Successful treatment of a classic Hodgkin lymphoma-type post-transplant lymphoproliferative disorder with tailored chemotherapy and Epstein–Barr virus-specific cytotoxic T lymphocytes in a pediatric heart transplant recipient. Pediatr Transpl. 2013;17:E168–73.CrossRefGoogle Scholar
- 22.Stein H, Pileri SA, Weiss LM, Poppema S, Gascoyne RD, Jaffe ES. Hodgkin lymphomas, introduction. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: International Agency for Research on Cancer; 2016. p. 424–30.Google Scholar